An Interview With The Team Leader  For The Scientific Discovery Of Pfizer’s Covid-19 Drug, Paxlovid In non-hospitalized high-risk adults with COVID-19, Paxlovid was found to reduce the risk of hospitalization or death by 89% compared to placebo.